featured
Immune Checkpoint Blockade Combined With Tumor-Specific Vaccine for Incurable HPV 16–Related Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical Trial
JAMA Oncol 2018 Sep 27;[EPub Ahead of Print], E Massarelli, W William, F Johnson, M Kies, R Ferrarotto, M Guo, L Feng, JJ Lee, H Tran, YU Kim, C Haymaker, C Bernatchez, M Curran, T Zecchini Barrese, J Rodriguez Canales, I Wistuba, L Li, J Wang, SH van der Burg, CJ Melief, B GlissonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.